Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 10th May 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0701 $0.104
52 weeks $0.0600 $0.85

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Oct 21, 2016 $16.50 $17.19 $16.35 $16.87 143 800
Oct 20, 2016 $16.04 $16.75 $15.92 $16.51 163 100
Oct 19, 2016 $16.41 $16.41 $15.66 $16.05 222 800
Oct 18, 2016 $16.38 $16.65 $16.16 $16.39 113 100
Oct 17, 2016 $16.21 $16.44 $15.89 $16.11 273 900
Oct 14, 2016 $17.86 $18.22 $16.11 $16.17 368 200
Oct 13, 2016 $17.53 $18.24 $17.39 $17.70 219 400
Oct 12, 2016 $19.37 $19.60 $17.81 $17.88 266 400
Oct 11, 2016 $20.25 $20.29 $19.14 $19.39 192 000
Oct 10, 2016 $19.79 $20.74 $19.67 $20.61 265 200
Oct 07, 2016 $20.30 $20.40 $19.37 $19.55 204 000
Oct 06, 2016 $20.46 $20.52 $19.87 $20.29 213 900
Oct 05, 2016 $20.25 $20.90 $19.56 $20.73 164 000
Oct 04, 2016 $19.80 $20.63 $19.73 $20.25 207 300
Oct 03, 2016 $19.79 $19.89 $19.33 $19.85 214 700
Sep 30, 2016 $19.75 $20.04 $19.33 $19.90 409 900
Sep 29, 2016 $20.78 $20.86 $19.86 $19.87 271 300
Sep 28, 2016 $20.70 $21.58 $20.36 $20.85 413 500
Sep 27, 2016 $19.68 $20.82 $19.25 $20.75 492 000
Sep 26, 2016 $20.47 $20.89 $19.34 $19.35 427 000
Sep 23, 2016 $20.10 $20.77 $19.43 $20.57 570 800
Sep 22, 2016 $19.91 $20.00 $19.09 $19.31 204 400
Sep 21, 2016 $19.80 $20.04 $19.02 $19.65 259 500
Sep 20, 2016 $19.70 $20.02 $19.45 $19.71 262 600
Sep 19, 2016 $19.96 $20.10 $19.34 $19.44 215 500
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT